Comparison of three transfusion protocols prior to central venous catheterization in patients with cirrhosis: A randomized controlled trial
- PMID: 31667992
- DOI: 10.1111/jth.14672
Comparison of three transfusion protocols prior to central venous catheterization in patients with cirrhosis: A randomized controlled trial
Abstract
Background: Transfusion of blood components prior to invasive procedures in cirrhosis patients is high and associated with adverse events.
Objectives: We compared three transfusion strategies prior to central venous catheterization in cirrhosis patients.
Patients/methods: Single center randomized trial that included critically ill cirrhosis patients with indication for central venous line in a tertiary private hospital in Brazil.
Interventions: Restrictive protocol, thromboelastometry-guided protocol, or usual care (based on coagulogram). The primary endpoint was the proportion of patients transfused with any blood component (ie, fresh frozen plasma, platelets, or cryoprecipitate). The secondary endpoints included incidence of bleeding and transfusion-related adverse events.
Results: A total of 57 patients (19 per group; 64.9% male; mean age, 53.4 ± 11.3 years) were enrolled. Prior to catheterization, 3/19 (15.8%) in the restrictive arm, 13/19 (68.4%) in the thromboelastometry-guided arm, and 14/19 (73.7%) in the coagulogram-guided arm received blood transfusion (odds ratio [OR], 0.07; 95% confidence interval [CI], 0.01-0.45; P = .002 for restrictive versus coagulogram-guided arm; OR, 0.09; 95% CI, 0.01-0.56; P = .006 for restrictive versus thromboelastometry-guided arm; and OR, 0.77; 95% CI, 0.14-4.15; P = .931 for thromboelastometry-guided versus coagulogram-guided arm). The restrictive protocol was cost saving. No difference in bleeding, length of stay, mortality, and transfusion-related adverse events was found.
Conclusions: The use of a restrictive strategy is associated with a reduction in transfusion prior to central venous catheterization and costs in critically ill cirrhosis patients. No effect on bleeding was found among the groups.
Trial registration: ClinicalTrials.gov NCT02311985.
Keywords: blood coagulation; central venous catheters; critical care; liver cirrhosis; thromboelastography.
© 2019 International Society on Thrombosis and Haemostasis.
Comment in
-
Reply to "Comment on 'Comparison of three transfusion protocols prior to central venous catheterization in patients with cirrhosis; a randomized controlled trial'".J Thromb Haemost. 2020 Mar;18(3):754-755. doi: 10.1111/jth.14737. J Thromb Haemost. 2020. PMID: 32112528 No abstract available.
-
Comment on Comparison of three transfusion protocols prior to central venous catheterisation in patients with cirrhosis; a randomised controlled trial.J Thromb Haemost. 2020 Mar;18(3):753-754. doi: 10.1111/jth.14732. J Thromb Haemost. 2020. PMID: 32112529 No abstract available.
-
Commentary on: Comparison of three transfusion protocols prior to central venous catheterization in patients with cirrhosis: A randomized controlled trial.J Thromb Haemost. 2020 Mar;18(3):558-559. doi: 10.1111/jth.14712. J Thromb Haemost. 2020. PMID: 32112536 No abstract available.
References
REFERENCES
-
- Parienti J-J, Mongardon N, Mégarbane B, et al. Intravascular complications of central venous catheterization by insertion site. N Engl J Med. 2015;373:1220-1229.
-
- Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med. 2000;132:391-402.
-
- McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348:1123-1133.
-
- Brass P, Hellmich M, Kolodziej L, Schick G, Smith AF. Ultrasound guidance versus anatomical landmarks for subclavian or femoral vein catheterization. Cochrane Database Syst Rev. 2015;1:CD011447.
-
- Zakeri N, Tsochatzis EA. Bleeding risk with invasive procedures in patients with cirrhosis and coagulopathy. Curr Gastroenterol Rep. 2017;19:45.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
